|Basic InformationLookupsLatest News|Zika Hijacks Pregnant Woman's Immune SystemHernia Patients May Need Fewer Opioids After Surgery, Study FindsHealth Tip: Prevent DehydrationTravel Tips for Contact Lens WearersHigher Odds of Infection With Reduced Kidney FunctionMost Ulcerative Colitis Patients Do Not Achieve Target RemissionOral Contraceptive Use Linked to Lower Rheumatoid Arthritis RiskKidney Disease May Boost Odds of InfectionZika May Not Last in Semen as Long as ThoughtVirtual House Calls for Speedy, Effective Parkinson's CareNearly 4 Million Worldwide Die Each Year From Asthma, COPDPowerful New Cholesterol Med Won't Harm Memory, Easing ConcernsDiverse Spectrum of Neurologic Syndromes Seen With ZikaExposure to Particulate Matter Linked to Metabolic AlterationsAir Purifiers May Help the Smog-Stressed Heart'Fat But Fit' a Myth?Statin Use Among Nursing Home Residents Varies SignificantlyZika Virus Tied to Neurological Woes in AdultsAn Expert's Guide to Preventing Food PoisoningHeart Risk Up if Hospitalized for Pneumonia or SepsisSinging May Be Good Medicine for Parkinson's PatientsCPAP Doesn't Alter Renal Function in Coexisting OSA, CVDWhen Stress Hormone Falters, Your Health May SufferKidney Disease May Boost Risk of Abnormal HeartbeatCertain Jobs Linked to Raised Risk of Rheumatoid ArthritisMidlife Vascular Risk Factors Tied to Increased Risk of DementiaHigher Risk of CVD Persists After Hospital Stay for Severe InfectionAntibiotic Doesn't Prevent Lung Complication After Stem Cell TransplantHealth Tip: One of Three Adults Gets ShinglesBlood Pressure Fluctuations Tied to Dementia Risk in StudyDecline in Kids' Ear Infections Linked to Pneumococcal VaccineFDA Approves Mavyret for Hepatitis CDoes Less Sleep Make You Less Healthy?Diabetes Drug Shows Promise Against Parkinson'sReview Suggests Benefits of Aerobic Exercise in FibromyalgiaNovel Procedure Improves Kidney Transplant SuccessABP 501, Adalimumab Biosimilar, Safe and Effective, for PsoriasisSimilar Defects ID'd for T2DM, Chronic Pancreatitis and DiabetesScientists Gain Insight Into AllergiesHealth Tip: Cooling a Heat RashKnow the Signs of ConcussionDo Your Pearly Whites Sometimes Cause You Pain?Rates of Inflammatory Bowel Disease Down in Rural AreasZika Probably Not Spread Through Saliva: StudyDrug for Kidney Disease Tied to Infection RiskGum Disease May Be Linked to Cancer Risk in Older WomenStent Surgery Could Benefit Select Glaucoma PatientsBlood Proteins Linked to Severity of Chronic Fatigue SyndromeDrowning Can Occur Hours After SwimmingClimate Change May Trigger 60,000 More Premature Deaths by 2030Questions and AnswersLinksBook Reviews
'Good' Donor Bacteria Can Last Long Term in Stool Transplant Patients
by -- Robert Preidt
Updated: Jun 16th 2017
FRIDAY, June 16, 2017 (HealthDay News) -- Researchers say their small study offers the first proof that therapeutic donor microbes remain for months or years in patients who've undergone stool transplants.
Medically known as "fecal microbiota transplantation" (FMT), the procedure is used to treat severe diarrhea and colitis caused by repeated Clostridium difficile infections, the researchers explained.
FMT is an increasingly popular treatment for C. difficile infections, with a 90 percent success rate. It involves collecting stool from a healthy donor and mixing it with salt water. The solution is then transferred to the patient's digestive tract through a thin, flexible tube called a colonoscope, or through the nose.
C. difficile gut infections can be deadly. They often follow use of antibiotics that change the normal balance of bacteria in a patient's gut. C. difficile is increasingly resistant to standard antibiotic treatments.
The aim of a fecal transplant is to restore beneficial gut bacteria. A balance of good and bad bacteria makes it easier to fight infection.
The study included seven patients. In two, some donor microbe strains persisted as long as two years after a transplant. In five others, donor strains persisted for three to six months, according to the University of Alabama at Birmingham researchers.
They were led by Ranjit Kumar, a biomedical informatics specialist.
"The demonstration that certain transplanted microbes can persist for up to two years demonstrates the potential of using FMT for long-term changes in the composition of the gastrointestinal tract microbe communities," the researchers wrote.
They said the results offer insights "that are essential for development of new approaches to improve health via manipulation of this complex microbial community."
The Alabama researchers added that the method they used to zero in on specific strains of gut bacteria for their study may help warn of changes related to illnesses like diabetes, obesity, ulcerative colitis or Parkinson's disease.
"This early warning system could be used to signal the use of interventions, such as microbe transplants, designed to maintain the gut microbe community structure necessary for efficient metabolic function needed for human health," said study co-author Casey Morrow, retired professor of cell, developmental and integrative biology.
The study was published online recently in the journal Biofilms and Microbiomes.
For more on FMT, go to the Fecal Transplant Foundation.
This article: Copyright © 2017 HealthDay. All rights reserved.